Penile Ischemia for Hypospadias Repair and The Patients and Surgeons Reported Outcomes

February 22, 2021 updated by: Mansoura University

Penile Ischemia for Hypospadias Repair and The Patients and Surgeons Reported Outcomes. A Prospective Randomized Study

Although haemostasis aimed to maintain bloodless surgical field for better exposure for the surgeon, cosmetic impact, and decreased breakdown of repair, there is no trials regarding the impact of haemostasis techniques on surgeon satisfaction during surgery and patients reported outcomes.

Study Overview

Study Type

Interventional

Enrollment (Actual)

110

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Outside U.S./Canada
      • Mansoura, Outside U.S./Canada, Egypt, 35516
        • Urology and nephrology center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 months to 3 years (CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • distal penile hypospadias were eligible for tubularized incided plate (TIP) urethroplasty repair

Exclusion Criteria:

  • coagulopathy
  • sickle cell disease or sickle cell trait
  • circumcised patient
  • history of previous failed surgery
  • severe chordee (>30 degree after degloving).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Tourniquet
tubularized incided plate (TIP) urethroplasty plus tourniquet
tubularized incided plate (TIP) urethroplasty plus tourniquet
EXPERIMENTAL: Non-tourniquet
tubularized incided plate (TIP) urethroplasty plus non-tourniquet
tubularized incided plate (TIP) urethroplasty plus non-tourniquet

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
assess Intraoperative blood loss
Time Frame: 12 months
by blood loss in milliliter in used gauze piece
12 months
bipolar diathermy use
Time Frame: 12 months
by number of bipolar diathermy usage
12 months
Surgeon satisfaction about haemostasis
Time Frame: 12 months
Surgeon satisfaction 4-tiered questionnaire (very satisfied, satisfied, unsatisfied and very unsatisfied).
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient-reported satisfaction
Time Frame: 24 months
by hypospadias objective scoring evaluation (HOSE) questionnaire
24 months
Long term complication rate
Time Frame: 60 months
number of surgery related complication after 5 years post operative
60 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Mohammed Dawaba, PhD, Mansoura University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 1, 2017

Primary Completion (ACTUAL)

December 1, 2018

Study Completion (ACTUAL)

December 1, 2019

Study Registration Dates

First Submitted

January 20, 2020

First Submitted That Met QC Criteria

January 20, 2020

First Posted (ACTUAL)

January 23, 2020

Study Record Updates

Last Update Posted (ACTUAL)

February 24, 2021

Last Update Submitted That Met QC Criteria

February 22, 2021

Last Verified

February 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • TOURNIQUE.HYPOSPADIAS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypospadias

Clinical Trials on Tourniquet

3
Subscribe